
Kristin Ann Vajda
Examiner (ID: 10363, Phone: (571)270-5232 , Office: P/1626 )
| Most Active Art Unit | 1622 |
| Art Unit(s) | 4131, 1622, 1626 |
| Total Applications | 2296 |
| Issued Applications | 1831 |
| Pending Applications | 129 |
| Abandoned Applications | 372 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19543060
[patent_doc_number] => 20240360096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => CANNABINOIDS FROM SUBSTITUTED RESORCINOL CARBOXYLIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 18/553525
[patent_app_country] => US
[patent_app_date] => 2022-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4617
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18553525
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/553525 | CANNABINOIDS FROM SUBSTITUTED RESORCINOL CARBOXYLIC ACIDS | Mar 31, 2022 | Abandoned |
Array
(
[id] => 20645811
[patent_doc_number] => 12600745
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-14
[patent_title] => Process for preparing B-[(7a, 1713)-17-hydroxy-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-trien-3-yl]-boronic acid
[patent_app_type] => utility
[patent_app_number] => 18/281943
[patent_app_country] => US
[patent_app_date] => 2022-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18281943
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/281943 | Process for preparing B-[(7a, 1713)-17-hydroxy-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-trien-3-yl]-boronic acid | Mar 28, 2022 | Issued |
Array
(
[id] => 17895289
[patent_doc_number] => 20220304951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => ANTICANCER COMPOSITIONS AND METHODS FOR USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/706565
[patent_app_country] => US
[patent_app_date] => 2022-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19988
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17706565
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/706565 | ANTICANCER COMPOSITIONS AND METHODS FOR USING SAME | Mar 27, 2022 | Abandoned |
Array
(
[id] => 20687666
[patent_doc_number] => 12617801
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-05
[patent_title] => Tetrahydrothieno pyridine derivatives as DDRS inhibitors
[patent_app_type] => utility
[patent_app_number] => 18/283867
[patent_app_country] => US
[patent_app_date] => 2022-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22506
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 210
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18283867
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/283867 | Tetrahydrothieno pyridine derivatives as DDRS inhibitors | Mar 24, 2022 | Issued |
Array
(
[id] => 18518482
[patent_doc_number] => 11708362
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-25
[patent_title] => Process for preparing aminopyrimidine derivatives
[patent_app_type] => utility
[patent_app_number] => 17/704718
[patent_app_country] => US
[patent_app_date] => 2022-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7333
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17704718
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/704718 | Process for preparing aminopyrimidine derivatives | Mar 24, 2022 | Issued |
Array
(
[id] => 17982528
[patent_doc_number] => 20220348564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => PHENYL-[1,3]DIOXOLO[4,5-C]PYRIDINYL-PHENYL-, PHENYL-[1,3]DIOXOLO[4,5-C]PYRIDINYL-HETEROARYL-, OR PHENYL-(1,3)DIOXO[4,5-C]PYRIDINYL-PIPERIDINYL-METHYL-OXETANYLMETHYL-1H-BENZO[D]IMIDAZOLE-CARBOXYLIC ACID DERIVATIVES AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/702835
[patent_app_country] => US
[patent_app_date] => 2022-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47969
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17702835
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/702835 | PHENYL-[1,3]DIOXOLO[4,5-C]PYRIDINYL-PHENYL-, PHENYL-[1,3]DIOXOLO[4,5-C]PYRIDINYL-HETEROARYL-, OR PHENYL-(1,3)DIOXO[4,5-C]PYRIDINYL-PIPERIDINYL-METHYL-OXETANYLMETHYL-1H-BENZO[D]IMIDAZOLE-CARBOXYLIC ACID DERIVATIVES AND METHODS OF USING SAME | Mar 23, 2022 | Abandoned |
Array
(
[id] => 19201374
[patent_doc_number] => 20240173273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-30
[patent_title] => USE OF PANTETHINE FOR THE TREATMENT OF SARS COV-2 INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/282677
[patent_app_country] => US
[patent_app_date] => 2022-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7574
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18282677
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/282677 | USE OF PANTETHINE FOR THE TREATMENT OF SARS COV-2 INFECTIONS | Mar 22, 2022 | Pending |
Array
(
[id] => 18211329
[patent_doc_number] => 20230057592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => USE OF H3K9me3 MODULATION FOR ENHANCING COGNITIVE FUNCTION
[patent_app_type] => utility
[patent_app_number] => 17/697893
[patent_app_country] => US
[patent_app_date] => 2022-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17697893
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/697893 | USE OF H3K9me3 MODULATION FOR ENHANCING COGNITIVE FUNCTION | Mar 16, 2022 | Abandoned |
Array
(
[id] => 19777360
[patent_doc_number] => 12226380
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-18
[patent_title] => Method of regulating immunity in the intestines
[patent_app_type] => utility
[patent_app_number] => 17/697089
[patent_app_country] => US
[patent_app_date] => 2022-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 4183
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17697089
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/697089 | Method of regulating immunity in the intestines | Mar 16, 2022 | Issued |
Array
(
[id] => 19233661
[patent_doc_number] => 20240190853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => FLUORINATED PYRIMIDINE COMPOUND AND METHOD FOR PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 18/282718
[patent_app_country] => US
[patent_app_date] => 2022-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5827
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18282718
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/282718 | Fluorinated pyrimidine compound and method for producing same | Mar 15, 2022 | Issued |
Array
(
[id] => 18700015
[patent_doc_number] => 11786501
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => Nitroxyl donors with improved therapeutic index
[patent_app_type] => utility
[patent_app_number] => 17/694500
[patent_app_country] => US
[patent_app_date] => 2022-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 21129
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17694500
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/694500 | Nitroxyl donors with improved therapeutic index | Mar 13, 2022 | Issued |
Array
(
[id] => 17850495
[patent_doc_number] => 20220280536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/653587
[patent_app_country] => US
[patent_app_date] => 2022-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14568
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17653587
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/653587 | Pharmaceutical composition | Mar 3, 2022 | Issued |
Array
(
[id] => 17945721
[patent_doc_number] => 20220332738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => PREPARATION METHOD OF A CYCLIC PHOSPHONATE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/653396
[patent_app_country] => US
[patent_app_date] => 2022-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7543
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17653396
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/653396 | Preparation method of a cyclic phosphonate compound | Mar 2, 2022 | Issued |
Array
(
[id] => 18147627
[patent_doc_number] => 20230021484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => Methods of Modifying Neuronal Function by Changing Intracellular Magnesium Levels
[patent_app_type] => utility
[patent_app_number] => 17/685944
[patent_app_country] => US
[patent_app_date] => 2022-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35645
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17685944
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/685944 | Methods of Modifying Neuronal Function by Changing Intracellular Magnesium Levels | Mar 2, 2022 | Abandoned |
Array
(
[id] => 18252360
[patent_doc_number] => 20230079399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => SUBSTITUTED QUINOLINE ANALOGS AS ALDEHYDE DEHYDROGENASE 1A1 (ALDH1A1) INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/682654
[patent_app_country] => US
[patent_app_date] => 2022-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44552
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17682654
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/682654 | Substituted quinoline analogs as aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors | Feb 27, 2022 | Issued |
Array
(
[id] => 17657033
[patent_doc_number] => 20220177498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => CRYSTALLINE FORM OF L-GLUFOSINATE AMMONIUM SALT AND PROCESS FOR PRODUCTION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/678283
[patent_app_country] => US
[patent_app_date] => 2022-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7887
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17678283
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/678283 | Crystalline form of L-glufosinate ammonium salt and process for production thereof | Feb 22, 2022 | Issued |
Array
(
[id] => 19187699
[patent_doc_number] => 20240166612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => ARYLTHIOETHER ACETAMIDE AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 18/275880
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42322
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -67
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18275880
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/275880 | ARYLTHIOETHER ACETAMIDE AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS | Feb 17, 2022 | Pending |
Array
(
[id] => 18764019
[patent_doc_number] => 11814405
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-14
[patent_title] => Pyridine sulfonamide phosphate compound, preparation method therefor, and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/675681
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4348
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17675681
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/675681 | Pyridine sulfonamide phosphate compound, preparation method therefor, and use thereof | Feb 17, 2022 | Issued |
Array
(
[id] => 19186161
[patent_doc_number] => 20240165074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => COMPOSITION OF THE PHYTOCOMPOUNDS INTENDED TO ENHANCE CYTOTOXIC ACTIVITY IN THE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA
[patent_app_type] => utility
[patent_app_number] => 18/549124
[patent_app_country] => US
[patent_app_date] => 2022-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3398
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18549124
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/549124 | COMPOSITION OF THE PHYTOCOMPOUNDS INTENDED TO ENHANCE CYTOTOXIC ACTIVITY IN THE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA | Feb 9, 2022 | Pending |
Array
(
[id] => 18558755
[patent_doc_number] => 11723980
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-15
[patent_title] => IRAK degraders and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/650545
[patent_app_country] => US
[patent_app_date] => 2022-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 381790
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 840
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17650545
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/650545 | IRAK degraders and uses thereof | Feb 9, 2022 | Issued |